References
- Heykants J., van Peer A., van de Velde V., et al. The clinical pharmacokinetics of itraconazole: an overview. Mycoses 1989; 32((suppl 1))67–87
- Hay R. J. Antifungal therapy of yeast infections. J Am Acad Dermatol 1994; 31: S6–9
- Debruyne D., Coquerel A. Pharmacokinetics of antifungal agents in onychomycoses. Clin Pharmacokinet 2001; 40: 441–72
- Matthieu L., de Doncker P., Cauwenbergh G., et al. Itraconazole penetrates the nail via the nail matrix and the nail bed – an investigation in onychomycosis. Clin Exp Dermatol 1991; 16: 374–6
- De Doncker P., Decroix J., Pierard G. E., et al. Antifungal pulse therapy for onychomycosis. A pharmacokinetic and pharmacodynamic investigation of monthly cycles of 1‐week pulse therapy with itraconazole. Arch Dermatol 1996; 132: 34–41
- Havu V., Brandt H., Heikkila H., et al. Continuous and intermittent itraconazole dosing schedules for the treatment of onychomycosis: a pharmacokinetic comparison. Br J Dermatol 1999; 140: 96–101
- Doncker P. D., Gupta A. K., Marynissen G., Stoffels P., Heremans A. Itraconazole pulse therapy for onychomycosis and dermatomycoses: an overview. J Am Acad Dermatol 1997; 37: 969–74
- Matsumoto T., Tanuma H., Nishiyama S. Clinical and pharmacokinetic investigations of oral intraconazole in the treatment of onychomycosis. Mycoses 1999; 42: 79–91
- Willemsen M., de Doncker P., Willems J., et al. Posttreatment itraconazole levels in the nail. New implications for treatment in onychomycosis. J Am Acad Dermatol 1992; 26: 731–5
- Gupta A. K., de Doncker P., Scher R. K., et al. Itraconazole for the treatment of onychomycosis. Int J Dermatol 1998; 37: 303–8
- Gupta A. K., Scher R. K., de Doncker P. Current management of onychomycosis. An overview. Dermatol Clin 1997; 15: 121–35
- Gupta A. K., Shear N. H. The new oral antifungal agents for onychomycosis of the toenails. J Eur Acad Dermatol Venereol 1999; 13: 1–13